News Archives - Page 17 of 1183 - BioHealth Innovation

News

November 11, 2024

U.S. FDA Removes Clinical Hold on Novavax’s COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial

GAITHERSBURG, Md., Nov. 11, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today…

Andy

Love0

News

November 11, 2024

Altimmune Announces Successful Completion of End-of-Phase 2 Meeting with FDA for Pemvidutide in the Treatment of Obesity

GAITHERSBURG, Md., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the successful completion of…

Andy

Love0

News

November 6, 2024

WBJ: Novavax taps AstraZeneca, Pfizer alum to lead key manufacturing site

Novavax Inc. (NASDAQ: NVAX) has tapped AstraZeneca and Pfizer alum Åsa Manelius to oversee operations at the Swedish lab where it manufactures a key vaccine ingredient that's…

Andy

Love0

News

November 6, 2024

Bethesda’s Vitrian Closes on $50M Initial Investment into Biomanufacturing Capacity & Launches Partnership with AmplifyBio

BETHESDA, Md. & WEST JEFFERSON, Ohio--(BUSINESS WIRE)--Vitrian, the leading end-to-end provider of investment capital and capacity building services for biomanufacturing,…

Andy

Love0

News

November 5, 2024

Catalyzing Crucial Cross-Border Collaborations and Innovation to Address Unmet Needs in Rare Diseases

The Indo US Bridging RARE Summit 2024 will spotlight the urgent need for cross-border collaborations to address disparities in rare…

Andy

Love0

News

November 4, 2024

Activation Capital Announces Frontier BioHealth Showcase Event

10 groundbreaking startups to pitch at Richmond's Main Street Station on November 20, 2024 RICHMOND, Va., Nov. 4, 2024 /PRNewswire/ -- Activation Capital, an innovation ecosystem…

Andy

Love0

News

November 4, 2024

QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics

Germantown, Maryland, and Venlo, the Netherlands, Nov. 04, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today…

Andy

Love0

News

November 4, 2024

Baltimore’s LaunchPort Welcomes Previous Crab Trap Winner, Nanochon, from JLABS as New Resident

Nov 3, 2024 LaunchPort is pleased to announce that Nanochon (https://www.nanochon.com/) has joined their City Garage/Baltimore Peninsula location as a LaunchPort…

Andy

Love0

News

November 4, 2024

BioTalk Podcast – Connecting Innovation to Opportunity: A Conversation with Rachel Rath, Head of JLABS @ Washington, DC

In this episode of BioTalk, Rich Bendis sits down with Rachel Rath, the Head of JLABS @ Washington, DC, to…

Andy

Love0

News

November 3, 2024

Join the Indo US Bridging RARE Summit 2024: Advancing Global Collaborations in Rare Disease Research

The Indo US Bridging RARE Summit 2024 is set to be an unmissable event for those dedicated to advancing rare…

Andy

Love0

News

U.S. FDA Removes Clinical Hold on Novavax’s COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial

Altimmune Announces Successful Completion of End-of-Phase 2 Meeting with FDA for Pemvidutide in the Treatment of Obesity

WBJ: Novavax taps AstraZeneca, Pfizer alum to lead key manufacturing site

Bethesda’s Vitrian Closes on $50M Initial Investment into Biomanufacturing Capacity & Launches Partnership with AmplifyBio

Catalyzing Crucial Cross-Border Collaborations and Innovation to Address Unmet Needs in Rare Diseases

Activation Capital Announces Frontier BioHealth Showcase Event

QIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnostics

Baltimore’s LaunchPort Welcomes Previous Crab Trap Winner, Nanochon, from JLABS as New Resident

BioTalk Podcast – Connecting Innovation to Opportunity: A Conversation with Rachel Rath, Head of JLABS @ Washington, DC

Join the Indo US Bridging RARE Summit 2024: Advancing Global Collaborations in Rare Disease Research

About BioHealth Innovation

Contact

Connect

News

About BioHealth Innovation

Contact

Connect

Search